Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

The Israeli study was conducted among 109,000 patients who were 40 years old or older.

READ MORE
 

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

D.C. Archbishop: Americans Must ‘Share Our Abundance’ With Illegal Aliens

The archbishop of Washington, DC, Cardinal Wilton Gregory says…
Read more

Biden Admin Ripped by Foreign Policy Think Tank for Inviting UN Envoy on Racism to Assess US

Secretary of State Anthony Blinken’s decision to invite United…
Read more

Jordan Has Been Attacked by Iranian-Made Drones – King Abdullah

Iranian-made drones and missiles have attacked Jordan in increasing…
Read more